Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

COPPOLA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.235
EU - Europa 5.725
AS - Asia 4.591
SA - Sud America 688
Continente sconosciuto - Info sul continente non disponibili 376
AF - Africa 154
OC - Oceania 13
Totale 21.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.036
SG - Singapore 1.758
RU - Federazione Russa 1.383
CN - Cina 1.124
IT - Italia 1.028
FI - Finlandia 715
UA - Ucraina 605
DE - Germania 572
BR - Brasile 536
HK - Hong Kong 485
VN - Vietnam 413
PL - Polonia 287
GB - Regno Unito 267
FR - Francia 231
IE - Irlanda 223
JP - Giappone 181
BD - Bangladesh 126
SE - Svezia 122
IN - India 108
CA - Canada 99
KR - Corea 87
TR - Turchia 60
NL - Olanda 57
RO - Romania 51
BE - Belgio 47
IQ - Iraq 43
CI - Costa d'Avorio 40
ZA - Sudafrica 37
AR - Argentina 36
MX - Messico 35
AT - Austria 30
VE - Venezuela 28
EC - Ecuador 26
PK - Pakistan 25
ES - Italia 23
CO - Colombia 22
IR - Iran 21
UZ - Uzbekistan 21
MA - Marocco 19
JM - Giamaica 18
MY - Malesia 18
CH - Svizzera 16
SA - Arabia Saudita 16
ID - Indonesia 15
PH - Filippine 14
DZ - Algeria 13
KE - Kenya 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
AL - Albania 9
AU - Australia 9
NP - Nepal 9
TN - Tunisia 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
JO - Giordania 8
LT - Lituania 8
PY - Paraguay 8
TH - Thailandia 7
EG - Egitto 6
EU - Europa 6
GR - Grecia 6
HN - Honduras 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
NI - Nicaragua 5
PA - Panama 5
PE - Perù 5
RS - Serbia 5
BG - Bulgaria 4
CG - Congo 4
DO - Repubblica Dominicana 4
GE - Georgia 4
KZ - Kazakistan 4
LB - Libano 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SN - Senegal 4
BB - Barbados 3
BN - Brunei Darussalam 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
MD - Moldavia 3
NO - Norvegia 3
PR - Porto Rico 3
SV - El Salvador 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
IL - Israele 2
OM - Oman 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AI - Anguilla 1
Totale 21.387
Salva come PNG Salva come JPEG
Città #
Ashburn 1.279
Singapore 1.172
Fairfield 875
Chandler 763
San Jose 617
Woodbridge 517
Hong Kong 476
Houston 410
Wilmington 409
Ann Arbor 404
Seattle 373
Jacksonville 328
Cambridge 262
Zgierz 257
Dublin 215
Medford 209
Moscow 206
Beijing 201
Santa Clara 181
Tokyo 179
Frankfurt am Main 169
Des Moines 157
Palermo 154
New York 148
Los Angeles 146
Council Bluffs 143
Nanjing 135
Ho Chi Minh City 134
Princeton 127
Lauterbourg 112
Hanoi 111
Boardman 103
Altamura 99
Tulsa 83
Dallas 80
Lawrence 75
Helsinki 70
Buffalo 67
San Diego 62
Dearborn 58
Milan 56
Hefei 54
São Paulo 52
Shenyang 49
Brussels 47
Nanchang 47
London 43
The Dalles 43
Abidjan 40
Chicago 40
Ludwigshafen am Rhein 40
Orem 40
Venice 38
Munich 36
Changsha 35
Jinan 34
Amsterdam 30
Columbus 29
Denver 29
Tianjin 29
Düsseldorf 28
Hebei 28
Nuremberg 28
Phoenix 28
Rome 27
Jiaxing 26
Johannesburg 26
Montreal 26
Springfield 26
San Mateo 23
Warsaw 22
Falls Church 20
Kumar 20
Seongnam 20
Toronto 20
Chennai 19
Bremen 18
Tashkent 18
Zhengzhou 18
City of London 17
Da Nang 17
Brooklyn 16
Guangzhou 16
Atlanta 15
San Paolo di Civitate 15
Haiphong 14
Izmir 14
Kunming 14
Shanghai 14
Stockholm 14
Dhaka 13
Istanbul 13
Poplar 13
Pune 13
Saint Petersburg 13
Tehran 13
Turin 13
Brasília 12
Ningbo 12
Paris 12
Totale 13.111
Salva come PNG Salva come JPEG
Nome #
ATRIAL FIBRILLATION AND MILD COGNITIVE IMPAIRMENT: WHAT CORRELATION? 321
Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes. 296
Critical limb ischaemia: definition and natural hystory 286
Bifocal stimulation in patient with congenitally corrected transposition of great vessels 276
ICD implantation in noncompaction of the left ventricular myocardium: a case report 273
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent. 257
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility 256
The QRS narrowing index for easy and early identification of responder to cardiac resynchronization therapy. 255
ST segment elevations: Always a marker of acute myocardial infarction? 253
Management of direct oral anticoagulants in patients with atrial fibrillation undergoing cardioversion 246
Ischemia critica cronica e vasculopatia ischemica polidistrettuale 244
INFLUENCE OF CAROTID AND PERIPHERAL ATHEROSCLEROSIS ON THE OUTCOME OF PATIENTS WITH ACUTE CORONARY SYNDROME 239
INCREASED LEVELS OF C-REACTIVE PROTEIN AND FIBRINOGEN INFLUENCE THE RISK OF VASCULAR EVENTS IN PATIENTS WITH NIDDM 238
Giant left atrium: a condition that is rarely seen today 235
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 234
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions 228
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation 224
Zonisamide in children and young adults with refractory epilepsy: An open label, multicenter Italian study 220
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation 219
Decision making and devices approach in a case of left main coronary artery thrombus. 217
Bicuspid aortic valve and unruptured sinus of Valsalva aneurysm, a rare association 216
The association between coronary microvascular dysfunction and carotid intima media thickness in patients with cardiac syndrome X 215
Measles and Brugada pattern: A case report 214
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study 213
Relationship between endothelial dysfunction, intima media thickness, hypertension and other cardiovascular risk factors in asymptomatic subjects 212
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: A report from the Euro Heart Survey on diabetes and the heart 212
A CASE REPORT OF ABNORMAL ORIGIN OF THE LEFT CORONARY ARTERY FROM THE RIGH CORONARY SINUS 211
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation 210
Alteration of Heart Rate Variability as an Early Predictor of Cardiovascular Events: A Look at Current Evidence 210
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation 209
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. 205
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey 202
Medical therapy for patients with subclinical and clinical carotid atherosclerosis 200
An update on the role of markers of inflammation in atherosclerosis 194
Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. 190
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart 189
Giant unruptured circumflex coronary artery aneurysms presenting as acute coronary syndrome 189
short term prognostic role of NT-proBNP in patients after myocardial infarction 188
Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art 187
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy. 185
A case of Takotsubo syndrome 184
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey) 183
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP 182
Short term prognostic role of NT-proBNP in patients after myocardial infarction 182
Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation 181
LA PRESENZA DI ELEVATI LIVELLI DI FIBRINOGENO E PROTEINA C-REATTIVA SONO SIGNIFICATIVAMENTE ASSOCIATI ALLA PRESENZA DI ATEROSCLEROSI CAROTIDEA NEI PAZIENTI IPERTESI O DIABETICI. 179
Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease 178
CAROTID INTMAL-MEDIAL THICKNESS ANS ENDOTHELIAL FUNCTION IN YOUNG ADULTS PATIENTS WITH MYOCARDIAL INFARCTION 175
Non-responders to cardiac resynchronization therapy: Insights from multimodality imaging and electrocardiography. A brief review 175
The risk of noncardiac surgery in patients with heart disease: a new way for an easy approach to a right preoperative assessment 174
takotsubo cardiomiopathy after acute diarrhea 174
Polycitemia vera and pulmonary embolism: case report 174
Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis 174
Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report 174
Focus sui non responder alla terapia di resincronizzazione cardiaca: orizzonti e prospettive 173
Vasospastic angina and scombroid syndrome: a case report 172
Significato clinico e prognostico dell'aterosclerosi carotidea nella valutazione del rischio cardiovascolare globale 172
Morbillo e fenomeno di Brugada: un caso clinico 170
C-REACTIVE PROTEIN AND FIBRINOGEN TO EVALUATE THE REAL RISK OF CEREBRO AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIEBETES MELLITUS 169
Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy 168
BENEFICI CLINICI E IMPATTO SULLA SOPRAVVIVENZA A LUNGO TERMINE DELLA TERAPIA DI RESINCRONIZZAZIONE CARDIACA 166
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. 166
Marshall's vein persistence: A rare and occasional finding during pacemaker implantation 166
INFLUENCE OF CAROTID AND PERIPHERAL ATHERLSCLEROSIS IN THE OUTCOME OF PATIENTS WITH ACUTE CORONARY SYNDROME 164
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 164
PREDICTION OF CEREBROVASCULAR AND CARDIOVASCULAR EVENTS IN PATIENTS WITH SUBLINICAL CAROTID ATHEROSCLEROSIS: THE ROLE OF C-REACTIVE PROTEIN 163
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol 163
Peripheral artery disease: potential role of ACE-inhibitor therapy 163
[Metabolic syndrome in children and in adults: is it an autonomous nosological entity?]. 163
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH EARLY ONSET OF HYPERTENSION OR TYPE-II DIABETES 161
Midventricular dyskinesia during clozapine treatment? 160
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy. 160
UN CASO CLINICO DI ATEROSCLEROSI POLIDISTRETTUALE 158
L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclerosi carotidea. 158
RELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION, INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN ASYMPTOMATIC SUBJECTS 157
IL MIOCARDIO NON COMPATTATO: UNA SERIE DI 177 CASI DEL REGISTRO ITALIANO DELLA SOCIETA’ ITALIANA DI ECOGRAFIA CARDIOVASCOLARE 157
INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA E FIBRILLAZIONE ATRIALE: UNO STUDIO RETROSPETTIVO SU 187 PAZIENTI 155
PREVALENCE OF A MILD COGNITIVE IMPAIRMENT IN PATIENTS WITH ATRIAL FIBRILLATION 155
FIBRINOGEN AS PREDICTOR OF MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: A 42-MONTHS FOLLOW-UP STUDY 152
In-hospital stay of patient with acute coronary syndrome with or without diabetes mellitus 152
Livelli plasmatici di fibrinogeno in soggetti con infarto miocardico acuto: relazione con gli eventi nel follow-up a 42 mesi 152
Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy 149
CAROTID INTIMAL-MEDIAL THICKNESS AND ENDOTHELIAL FUNCTION IN YOUNG ADULT PATIENTS WITH MYOCARDIAL INFARCTION. 147
JUGULAR PACING LEAD EXTRACTION WITH LASER SHEATH: A CASE REPORT. 146
EFFICACIA DELL’ATP IN PAZIENTI CON ICD E TV RAPIDE: UN CASO CLINICO 144
Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. 144
UN CASO CLINICO DI ATEROSCLEROSI POLIDISTRETTUALE 143
EVALUATION OF REMNANT CHOLESTEROL LEVELS AND MONOCYTE-TO-HDL-CHOLESTEROL RATIO IN SOUTH ASIAN PATIENTS WITH ACUTE CORONARY SYNDROME 142
NON INVASIVE VALUATION OF ENDOTHELIAL FUNCTION IN THE PATIENTS WITH ANDERSON- FABRY DISEASE 139
LA PROTEINA C REATTIVA ED IL FIBRINOGENO NELLA VALUTAZIONE DEL RISCHIO REALE DI EVENTI VASCOLARI IN PAZIENTI CON DIABETE MELLITO TIPO II. 137
Update on Brugada Syndrome 2019 137
TRIAL FIBRILLATION AND COGNITIVE IMPAIRMENT 136
LA TERAPIA DI RESINCRONIZZAZIONE CARDIACA (TRC) COME PONTE AL TRAPIANTO CARDIACO. UN CASO CLINICO 136
ELEVATED C-REATIVE PROTEIN LEVELS ARE STRONG PREDICTOR OF CLINICAL EVENTS IN HYPERTENSIVE PATIENTS WITH EARLY STAGES OF ATHEROSCLEROSIS 136
Use of statins in patients with peripheral artery disease 134
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension 130
La presenza di disfunzione endoteliale e di aterosclerosi carotidea sono forti predittori di eventi clinici in pazienti asintomatici. 128
The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: a pilot study 127
DYSLIPIDEMIA AND CARDIOVASCULAR RISK: FOCUS ON THE ROLE OF LOW HDL-CHOLESTEROL CONCENTRATIONS IN DEVELOPING ATHEROSCLEROTIC DISEASE AND IN ACCELERATING ITS PROGRESSION FROM SUBCLINICAL LESIONS TO CLINICAL EVENTS. EVIDENCES AND THERAPEUTICAL IMPLICATIONS. 126
RISCHIO CARDIOVASCOLARE GLOBALE E VASCULOPATIE PERIFERICHE 124
Totale 18.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.319 0 301 26 70 36 45 77 57 160 168 76 303
2022/20232.035 207 355 34 230 248 290 144 175 239 14 73 26
2023/2024855 38 128 45 125 49 181 119 47 8 22 13 80
2024/20252.213 45 144 143 187 93 112 197 145 165 227 294 461
2025/20268.026 540 189 377 550 820 1.200 1.021 838 545 1.328 351 267
2026/2027471 352 119 0 0 0 0 0 0 0 0 0 0
Totale 21.782